Literature DB >> 21347852

Escherichia coli topoisomerase I is an iron and zinc binding protein.

Jianxin Lu1, Wu Wang, Guoqiang Tan, Aaron P Landry, Peng Yi, Fan Si, Yaguang Ren, Huangen Ding.   

Abstract

Escherichia coli topoisomerase I (TopA) cleaves and rejoins one strand of double-stranded DNA to relax the negatively supercoiled DNA. Structurally, TopA contains an N-terminal catalytic fragment and a C-terminal zinc-binding region that is required for relaxation of the negatively supercoiled DNA. Here we report that E. coli TopA is an iron and zinc binding protein. The UV-Vis absorption measurements and metal content analyses reveal that TopA purified from E. coli cells grown in the rich LB medium contains both iron and zinc. However, TopA purified from E. coli cells grown in the M9 minimal medium has negligible amounts of zinc or iron and no topoisomerase activity. Nevertheless, supplement of exogenous zinc or iron in E. coli cells grown in the M9 minimal medium produces the zinc- or iron-bound TopA, respectively. Whereas the zinc-bound TopA is fully active to relax the negatively supercoiled DNA, the iron-bound TopA has little or no enzyme activity. Furthermore, excess iron in the M9 minimal medium is able to compete with the zinc binding in TopA in E. coli cells and attenuate the topoisomerase activity, suggesting that E. coli TopA may be modulated by iron and zinc binding in vivo.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21347852      PMCID: PMC3123405          DOI: 10.1007/s10534-011-9425-6

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  30 in total

Review 1.  DNA topoisomerases: harnessing and constraining energy to govern chromosome topology.

Authors:  Allyn J Schoeffler; James M Berger
Journal:  Q Rev Biophys       Date:  2008-02       Impact factor: 5.318

Review 2.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

3.  Viability of Escherichia coli topA mutants lacking DNA topoisomerase I.

Authors:  Vera A Stupina; James C Wang
Journal:  J Biol Chem       Date:  2004-11-01       Impact factor: 5.157

4.  Increased thermosensitivity associated with topoisomerase I deletion and promoter mutations in Escherichia coli.

Authors:  H Qi; R Menzel; Y C Tse-Dinh
Journal:  FEMS Microbiol Lett       Date:  1999-09-01       Impact factor: 2.742

5.  Functional characterization of iron-substituted tristetraprolin-2D (TTP-2D, NUP475-2D): RNA binding affinity and selectivity.

Authors:  Robert C diTargiani; Seung Jae Lee; Sarah Wassink; Sarah L J Michel
Journal:  Biochemistry       Date:  2006-11-14       Impact factor: 3.162

6.  Severe zinc depletion of Escherichia coli: roles for high affinity zinc binding by ZinT, zinc transport and zinc-independent proteins.

Authors:  Alison I Graham; Stuart Hunt; Sarah L Stokes; Neil Bramall; Josephine Bunch; Alan G Cox; Cameron W McLeod; Robert K Poole
Journal:  J Biol Chem       Date:  2009-04-19       Impact factor: 5.157

7.  Reactivity of nitric oxide with the [4Fe-4S] cluster of dihydroxyacid dehydratase from Escherichia coli.

Authors:  Xuewu Duan; Juanjuan Yang; Binbin Ren; Guoqiang Tan; Huangen Ding
Journal:  Biochem J       Date:  2009-02-01       Impact factor: 3.857

Review 8.  Phylogenomics of DNA topoisomerases: their origin and putative roles in the emergence of modern organisms.

Authors:  Patrick Forterre; Danièle Gadelle
Journal:  Nucleic Acids Res       Date:  2009-02-09       Impact factor: 16.971

Review 9.  Structural studies of type I topoisomerases.

Authors:  Nicole M Baker; Rakhi Rajan; Alfonso Mondragón
Journal:  Nucleic Acids Res       Date:  2008-12-23       Impact factor: 16.971

Review 10.  Bacterial topoisomerase I as a target for discovery of antibacterial compounds.

Authors:  Yuk-Ching Tse-Dinh
Journal:  Nucleic Acids Res       Date:  2008-11-28       Impact factor: 16.971

View more
  6 in total

Review 1.  Research progress on gut microbiota in patients with gastric cancer, esophageal cancer, and small intestine cancer.

Authors:  Changchang Chen; Linjie Chen; Lijun Lin; Dazhi Jin; Yaoqiang Du; Jianxin Lyu
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-26       Impact factor: 4.813

2.  Iron and zinc binding activity of Escherichia coli topoisomerase I homolog YrdD.

Authors:  Zishuo Cheng; Guoqiang Tan; Wu Wang; Xiaolu Su; Aaron P Landry; Jianxin Lu; Huangen Ding
Journal:  Biometals       Date:  2014-01-29       Impact factor: 2.949

Review 3.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

4.  Iron inhibits Escherichia coli topoisomerase I activity by targeting the first two zinc-binding sites in the C-terminal domain.

Authors:  Wu Wang; Xiaolu Su; Xiaobing Wang; Juanjuan Yang; Ting Zhang; Maofeng Wang; Rugen Wan; Guoqiang Tan; Jianxin Lu
Journal:  Protein Sci       Date:  2014-09-13       Impact factor: 6.725

5.  Inhibition of Zn(II) binding type IA topoisomerases by organomercury compounds and Hg(II).

Authors:  Bokun Cheng; Thirunavukkarasu Annamalai; Shayna Sandhaus; Priyanka Bansod; Yuk-Ching Tse-Dinh
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

6.  Zinc Toxicity and Iron-Sulfur Cluster Biogenesis in Escherichia coli.

Authors:  Jianghui Li; Xiaojun Ren; Bingqian Fan; Zhaoyang Huang; Wu Wang; Huaibin Zhou; Zhefeng Lou; Huangen Ding; Jianxin Lyu; Guoqiang Tan
Journal:  Appl Environ Microbiol       Date:  2019-04-18       Impact factor: 4.792

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.